Na(+),K(+)-
ATPase is a housekeeping pump in virtually all animal cells. Recently,
cardiac glycosides that inhibit Na(+),K(+)-
ATPase have been reported to be candidate for novel anticancer drug. Here, we investigated clinical significance of Na(+),K(+)-
ATPase alpha1-isoform (alpha 1NaK), alpha2-isoform (alpha 2NaK) and alpha 3-isoform (alpha 3NaK) in
hepatocellular carcinoma (HCC). Interestingly, the expression levels of alpha 3NaK
protein in HCC tissues were significantly higher than those in the accompanying non-
tumor tissues, whereas no significant increases in expression of alpha 1NaK and alpha 2NaK
proteins were observed in HCC compared to non-
tumor tissues. The
ouabain (10 microM)-sensitive K(+)-
ATPase activities (Na(+),K(+)-
ATPase activities) in the membrane fraction from HCC tissue were significantly higher than those from non-
tumor tissues. The Na(+),K(+)-
ATPase activity was positively and significantly correlated with the expression level of alpha 3NaK. Apparent affinity for Na(+) in the Na(+),K(+)-
ATPase activity in HCC tissues was significantly lower than that in non-
tumor tissues, consistent with an elevated expression of alpha 3NaK relative to alpha 1NaK. Our results suggest that overexpression of alpha 3NaK increases the Na(+),K(+)-
ATPase activity of HCC cells.